Doxorubicin Hydrochloride Liposome
NDC 0338-0086, Doxorubicin Hydrochloride Liposome, injection, suspension, liposomal, from Baxter Healthcare Company.
- Product NDC
- 0338-0086
- Status
- Listed
- Labeler
- Baxter Healthcare Company
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA050718
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0338-0086 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXORUBICIN HYDROCHLORIDE2 mg/mL
Pharmacologic classes
Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0338-0086-01 | 00338008601 | 1 VIAL, SINGLE-USE in 1 CARTON (0338-0086-01) / 25 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cf25a018-e795-49e4-8533-a581f8366dd9
Use it
Look up 0338-0086 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0338-0086 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0338-0086. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.